SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Aetna, Inc.
___________________________________________
(Name of Issuer)
Common Stock
___________________________________________
(Title of Class and Securities)
008117103
___________________________________________
(CUSIP Number of Class of Securities)
O. Mason Hawkins
Chairman of the Board and C.E.O.
and
Charles D. Reaves
Vice President & General Counsel
Southeastern Asset Management, Inc.
6410 Poplar Avenue; Suite 900
Memphis, TN 38119
(901) 761-2474
___________________________________________________________
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
March 3, 2000
___________________________________________
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
Schedule because of Sections 240.13d-1(e), 240.13d-1(f), or 240.13d-1(g), check
the following box: [X]
CUSIP No. 008117103 13D
___________________________________________________________________
(1) NAMES OF REPORTING PERSONS
Southeastern Asset Management, Inc. I.D. No. 62-0951781
___________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a)
(b) X
___________________________________________________________________
(3) SEC USE ONLY
___________________________________________________________________
(4) SOURCE OF FUNDS
OO: Funds of investment advisory clients
___________________________________________________________________
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ]
___________________________________________________________________
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Tennessee
___________________________________________________________________
:(7) SOLE VOTING POWER
: (Discretionary Accounts)
NUMBER OF SHARES BENEFICIALLY : 5,577,100 shares
OWNED BY EACH REPORTING PERSON ________________________________
WITH :(8) SHARED OR NO VOTING POWER
: 1,768,400 shares (Shared)
1,124,300 shares (None)
________________________________
:(9) SOLE DISPOSITIVE POWER
: (Discretionary Accounts)
: 6,701,400 shares
________________________________
:(10) SHARED DISPOSITIVE POWER
: 1,768,400 shares
___________________________________________________________________
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,469,800 shares
___________________________________________________________________
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES
CERTAIN SHARES
___________________________________________________________________
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
6.0%
___________________________________________________________________
(14) TYPE OF REPORTING PERSON
IA
___________________________________________________________________
CUSIP No. 008117103 13D
___________________________________________________________________
(1) NAMES OF REPORTING PERSONS
O. Mason Hawkins I.D. No. ###-##-####
___________________________________________________________________
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a)
(b) X
___________________________________________________________________
(3) SEC USE ONLY
___________________________________________________________________
(4) SOURCE OF FUNDS
OO: None
___________________________________________________________________
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ]
___________________________________________________________________
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Citizen of United States
___________________________________________________________________
:(7) SOLE VOTING POWER
: (Discretionary Accounts)
NUMBER OF SHARES BENEFICIALLY : None
OWNED BY EACH REPORTING PERSON ________________________________
WITH :(8) SHARED VOTING POWER
: None
________________________________
:(9) SOLE DISPOSITIVE POWER
: None
________________________________
:(10) SHARED DISPOSITIVE POWER
: None
___________________________________________________________________
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None (See Item 2 )
___________________________________________________________________
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES
CERTAIN SHARES
___________________________________________________________________
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
0.0%
___________________________________________________________________
(14) TYPE OF REPORTING PERSON
IN
___________________________________________________________________
Item 1. Security and Issuer
The class of equity security to which this statement on Schedule 13D
relates is the common stock (the "Securities") of Aetna, Inc., a Connecticut
corporation (the "Issuer"). The Issuer has its principal executive offices
located at 151 Farmington Avenue, Hartford, Connecticut 06156.
Item 2. Identity and Background
Subparagraphs (a), (b), and (c). This statement is being filed by
Southeastern Asset Management, Inc. ("Southeastern"), an investment advisor
registered with the Securities & Exchange Commission under the Investment
Advisers Act of 1940, as amended. The address of its principal office is 6410
Poplar Avenue, Suite 900, Memphis, Tennessee 38119. Southeastern serves as an
investment advisor to various individual clients, institutions(including
qualified retirement plans), endowment funds and to Longleaf Partners Funds
Trust ("Longleaf"), a registered investment company organized as a
Massachusetts business trust and having four series or portfolios. One of its
series, Longleaf Partners Fund, owns Securities of the Issuer. Neither
Longleaf Partners Fund nor any other managed account owns as much as 5% of the
outstanding Securities. Longleaf Partners Fund may be reached c/o Southeastern
Asset Management, Inc., 6410 Poplar Avenue, Suite 900, Memphis, Tennessee
38119.
The Securities of the Issuer reported in Item 5 herein were acquired
on behalf of the investment advisory clients of Southeastern Asset Management,
Inc., including Longleaf Partners Fund, under sole or shared discretionary
authority granted Southeastern. None of the Securities are owned by or on
behalf of Southeastern or by any of its directors or officers, or any Trustees
or officers of Longleaf.
This statement is also being filed by Mr. O. Mason Hawkins, Chairman of
the Board and Chief Executive Officer of Southeastern, in the event he could be
deemed to be an indirect beneficial owner of the Securities reported by
Southeastern through the exercise of voting control and/or dispositive power
over the Securities as the result of his official positions or ownership of
voting securities of Southeastern. Neither Southeastern nor Mr. Hawkins owns
any Securities for its or his own account and each disclaims beneficial
interest in any of the Securities reported herein.
(d) During the last five years, neither Southeastern, the series of
Longleaf Partners Funds Trust, nor Mr. Hawkins has been convicted in any
criminal proceeding.
(e) During the last five years, neither Southeastern, the series of
Longleaf Partners Funds Trust, nor Mr. Hawkins has been a party to any civil or
administrative proceeding involving any alleged violations of any securities
laws.
(f) Southeastern is a corporation organized and existing under the
laws of the State of Tennessee; Longleaf Partners Funds Trust is a
Massachusetts business trust. Mr. Hawkins is a citizen of the United States.
The names, business addresses, and principal occupations of each director and
executive officer of Southeastern are set forth in Schedule I.
Item 3. Source and Amount of Funds or Other Consideration
The respective investment advisory clients of Southeastern used
approximately $ 444,336,522 in the aggregate to purchase the Securities
reported in this filing. All assets used to purchase Securities were assets of
these respective clients and none were assets of Southeastern. In addition,
none of the proceeds used to purchase the Securities were provided through
borrowings of any nature.
Item 4. Purpose of Transaction
The Securities reported in this filing have been purchased and held
for investment purposes on behalf of client accounts over which Southeastern
has either sole or shared discretionary investment or voting power. The
Securities are reported by Southeastern and by Mr. O. Mason Hawkins, Chairman
of the Board and Chief Executive Officer in the event that either should be
deemed to be a member of a group under Section 13(d)(3) or the beneficial owner
of these Securities under the provisions of subparagraph (b)of Rule 13d-3 under
the Securities Exchange Act of 1934. Beneficial ownership on the part of
Southeastern and Mr. Hawkins as members of a group or as beneficial owners is
expressly disclaimed, as permitted by Rule 13d-4. All purchases of Securities
were made for investment purposes only, in the ordinary course of business of
Southeastern as a registered investment advisor. Southeastern may purchase
additional Securities on behalf of clients in the future, or may sell all or a
part of the current holdings of the Securities.
Southeastern is engaged in the business of investment management of
its clients' assets and pursues an investment philosophy of identifying
undervalued situations and acquiring positions in undervalued companies on
behalf of its clients. In pursuing this investment philosophy, Southeastern
analyzes the operations, capital structure and markets of companies in which
its clients invest and continuously monitors the business operations of such
companies through analysis of financial statements and other public documents,
through discussions with knowledgeable industry observers, and with management
of such companies, often at management's invitation.
Southeastern qualifies as an institution which may elect to file
securities ownership reports required by the Securities Exchange Act of 1934 on
Schedule 13G and, as a routine matter, Southeastern utilizes Schedule 13G for
its reporting of the ownership positions held by its investment advisory
clients. As the result of investment analysis or the occurrence of events,
Southeastern may desire to participate in discussions with the particular
portfolio company's management or with third parties about significant matters
in which Southeastern may suggest possible courses of action to assist in
building corporate intrinsic value per share or to cause the Company's true
economic value to be recognized. In such situations, Southeastern may elect
to file Schedule 13D, or to convert an existing filing on Schedule 13G to a
filing on Schedule 13D, in order to be more active in corporate governance and
management matters, and to have the ability to enter into discussions with
third parties concerning proposed corporate transactions of a significant
nature.
In this situation, Southeastern has had conversations with third parties,
and intends to have additional conversations with these and one or more other
third parties and/or the Issuer's management, regarding actions or transactions
of the type described in clauses (a) through (j) of Item 4 of the Schedule 13D
form. To obtain the necessary flexibility to discuss any such actions or
transactions with any such third parties or with the Issuer's management,
Southeastern is filing Schedule 13D. Southeastern will thus be able to discuss
any such proposals with the respective third parties and/or with management of
the Issuer as a means of fulfilling its fiduciary duties to its clients. As the
result of this filing on Schedule 13D, and depending on the circumstances,
Southeastern and its clients could support one or more of the actions or
transactions described in clauses (a) through (j) of Item 4 of the Schedule 13D
form.
Item 5. Interest In Securities Of The Issuer
(a) The aggregate number and percentage of Securities to which this
Schedule 13D relates is 8,469,800 shares of the common stock of
the Issuer, constituting approximately 6.0% of the 141,289,941
shares outstanding.
Common % of outstanding
Shares Common Shares
Held
___________________________________________________________________
Voting Authority
Sole: 5,577,100 3.9%
Shared: 1,768,400* 1.3%
None: 1,124,300 0.8%
Total 8,469,800 6.0%
*Consists of 1,768,400 shares owned by Longleaf Partners Fund, a series of
Longleaf Partners Funds Trust, an open-end management investment company
registered under the Investment Company Act of 1940.
Dispositive Authority
Sole: 6,701,400 4.7%
Shared: 1,768,400* 1.3%
Total 8,469,800 6.0%
*Consists of 1,768,400 shares owned by Longleaf Partners Fund, a series of
Longleaf Partners Funds Trust, an open-end management investment company
registered under the Investment Company Act of 1940.
(b) Southeastern generally has the sole power to dispose of or to
direct the disposition of the Securities held for discretionary accounts of its
investment clients, and may be granted the sole power to vote or direct the
vote of such Securities; such powers may be retained by or shared with the
respective clients for shared or non-discretionary accounts, for which
Southeastern generally makes recommendations with respect thereto. Shares held
by any Series of Longleaf Partners Funds Trust are reported in the "shared"
category.
(c) All purchase or sale transactions in the Securities during the
past sixty days are set forth on Schedule II.
(d) The investment advisory clients of Southeastern have the sole
right to receive and, subject to notice, to withdraw the proceeds from the sale
of the Securities, and the sole power to direct the receipt of dividends from
any of the Securities held for their respective accounts. Such clients may
also terminate the investment advisory agreements without penalty upon
appropriate notice. Southeastern does not have an economic interest in any of
the Securities reported herein.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer
The powers of disposition with respect to Securities owned by
discretionary private accounts of Southeastern are established in written
investment advisory agreements between clients and Southeastern, which are
entered into in the normal and usual course of the business of Southeastern as
a registered investment advisor and which are generally applicable to all
securities purchased for the benefit of each such discretionary private
account. There are no special or different agreements relating to the
Securities of the Issuer.
The written investment advisory agreements with clients do not
contain provisions relating to borrowing of funds to finance the acquisition of
the Securities, acquisition of control, transfer of securities, joint ventures,
or any of the other transactions listed in the instructions to Item 7 of
Schedule 13D other than voting of proxies. In connection with voting,
Southeastern may be allowed or directed to vote the proxies received by
accounts classified as "discretionary" or "shared" accounts; such authority is
generally retained by the clients for accounts classified as "non-
discretionary".
Item 7. Material to be Filed as an Exhibit
Schedule I. Information with Respect to Directors and Officers of Southeastern
Asset Management, Inc.
Schedule II. Purchase and sale transactions within the past 60 days.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: March 8, 2000
SOUTHEASTERN ASSET MANAGEMENT, INC.
By /s/ Charles D. Reaves
_______________________________
Charles D. Reaves
Vice President & General Counsel
O. MASON HAWKINS
(Individually)
/s/ O. Mason Hawkins
_______________________________
Joint Filing Agreement
In accordance with Rule 13d-1(f) under the Securities Exchange Act
of 1934, the persons or entities named below agree to the joint
filing on behalf of each of them of this Schedule 13G with respect
to the Securities of the Issuer and further agree that this joint
filing agreement be included as an exhibit to this Schedule 13G. In
evidence thereof, the undersigned hereby execute this Agreement as
of the 8th day of March, 2000.
Southeastern Asset Management, Inc.
By /s/ Charles D. Reaves
_______________________________________________
Charles D. Reaves
Vice President and General Counsel
O. Mason Hawkins, Individually
/s/ O. Mason Hawkins
_______________________________________________
SCHEDULE I
Information with Respect to Executive
Officers and Directors
The following information is disclosed for each of the directors and
executive officers of Southeastern: name; business address; and present
principal occupation or employment and the name, principal business and address
of any corporation or other organization in which such employment is conducted.
Unless otherwise specified, the principal employer of each such individual
is Southeastern Asset Management, Inc., having its principal executive offices
located at 6410 Poplar Ave., Suite 900, Memphis, Tennessee 38119. Each
individual identified below is a citizen of the United States.
To the knowledge of management of Southeastern, during the last five years,
no such person has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors), and no such person was a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction as a
result of which he was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities law or finding any violation with respect to
such laws.
SOUTHEASTERN ASSET MANAGEMENT, INC.
Directors
O. Mason Hawkins: Director, Chairman of the Board and Chief Executive Officer
of Southeastern Asset Management, Inc.; Chairman of the Board, Chief Executive
Officer, Co-Portfolio Manager of Longleaf Partners Funds.
G. Staley Cates: Director and President of Southeastern Asset Management,
Inc.; Trustee, President and Co-Portfolio Manager Longleaf Partners Funds.
Frank N. Stanley, III: Director and Vice President of Southeastern Asset
Management, Inc.
Other Officers
James H. Barton Vice President
John B. Buford Vice President
C. T. Fitzpatrick Vice President
Lee B. Harper Vice President
Randy D. Holt Vice President and Secretary
Andrew R. McCarroll Vice President and Assistant General Counsel
E. Andrew McDermott Vice President
Joseph L. Ott Vice President and Treasurer
Charles D. Reaves Vice President and General Counsel
Deborah L. Sullivan Vice President-Trading
James E. Thompson, Jr. Vice President
SCHEDULE II
PURCHASE ("by") AND SALE ("sl") TRANSACTIONS WITHIN PAST 60 DAYS
All purchases and sales listed below were normal, open-market transactions.
Tran Trade
Type Security Date Quantity Total Price Per Share
---- -------------------------- ------------------------ ------------
by Aetna, Inc. 01-06-00 45,000 2,436,043 54.134
by Aetna, Inc. 01-06-00 209,000 11,314,069 54.134
by Aetna, Inc. 01-06-00 17,000 922,420 54.260
by Aetna, Inc. 01-06-00 350,500 18,974,072 54.134
by Aetna, Inc. 01-07-00 2,600 141,238 54.322
by Aetna, Inc. 01-07-00 38,300 2,136,370 55.780
by Aetna, Inc. 01-10-00 36,000 2,041,369 56.705
by Aetna, Inc. 01-10-00 15,000 850,570 56.705
by Aetna, Inc. 01-10-00 12,000 680,456 56.705
by Aetna, Inc. 01-10-00 13,000 737,161 56.705
by Aetna, Inc. 01-10-00 44,000 2,495,007 56.705
by Aetna, Inc. 01-10-00 4,000 226,819 56.705
by Aetna, Inc. 01-10-00 31,000 1,757,846 56.705
by Aetna, Inc. 01-10-00 6,100 353,098 57.885
by Aetna, Inc. 01-10-00 190,000 10,773,893 56.705
by Aetna, Inc. 01-10-00 30,000 1,701,141 56.705
by Aetna, Inc. 01-11-00 100,000 5,700,750 57.008
by Aetna, Inc. 01-11-00 50,000 2,850,375 57.008
by Aetna, Inc. 01-11-00 40,000 2,267,400 56.685
by Aetna, Inc. 01-11-00 9,000 511,855 56.873
by Aetna, Inc. 01-11-00 56,400 3,204,789 56.823
by Aetna, Inc. 01-11-00 150,000 8,551,125 57.008
by Aetna, Inc. 01-11-00 20,000 1,132,000 56.600
by Aetna, Inc. 01-13-00 25,000 1,413,895 56.556
by Aetna, Inc. 01-13-00 20,000 1,138,900 56.945
by Aetna, Inc. 01-13-00 6,400 362,213 56.596
by Aetna, Inc. 01-13-00 12,000 683,340 56.945
by Aetna, Inc. 01-13-00 29,000 1,641,400 56.600
by Aetna, Inc. 01-14-00 6,000 337,736 56.289
by Aetna, Inc. 01-14-00 18,000 1,013,207 56.289
by Aetna, Inc. 01-14-00 10,000 562,893 56.289
by Aetna, Inc. 01-14-00 10,000 562,893 56.289
by Aetna, Inc. 01-14-00 5,000 281,446 56.289
by Aetna, Inc. 01-14-00 5,000 281,446 56.289
by Aetna, Inc. 01-14-00 30,000 1,688,679 56.289
by Aetna, Inc. 01-14-00 10,600 599,691 56.575
by Aetna, Inc. 01-14-00 13,000 735,730 56.595
by Aetna, Inc. 01-14-00 25,000 1,407,232 56.289
by Aetna, Inc. 01-14-00 12,400 708,986 57.176
by Aetna, Inc. 01-14-00 123,500 6,951,729 56.289
by Aetna, Inc. 01-14-00 22,000 1,243,761 56.535
by Aetna, Inc. 01-18-00 25,000 1,403,312 56.132
by Aetna, Inc. 01-18-00 50,500 2,840,403 56.246
by Aetna, Inc. 01-18-00 8,000 448,980 56.123
by Aetna, Inc. 01-19-00 24,000 1,350,240 56.260
by Aetna, Inc. 01-19-00 55,500 3,120,571 56.227
by Aetna, Inc. 01-19-00 85,000 4,779,252 56.226
by Aetna, Inc. 01-19-00 20,000 1,124,530 56.227
by Aetna, Inc. 01-20-00 45,000 2,521,804 56.040
by Aetna, Inc. 01-20-00 8,000 448,321 56.040
by Aetna, Inc. 01-20-00 13,000 728,521 56.040
by Aetna, Inc. 01-20-00 27,500 1,541,103 56.040
by Aetna, Inc. 01-20-00 16,000 896,642 56.040
by Aetna, Inc. 01-20-00 12,000 672,481 56.040
by Aetna, Inc. 01-20-00 35,000 1,961,403 56.040
by Aetna, Inc. 01-20-00 61,000 3,418,446 56.040
by Aetna, Inc. 01-20-00 55,000 3,082,205 56.040
by Aetna, Inc. 01-20-00 10,000 560,401 56.040
by Aetna, Inc. 01-21-00 16,000 891,634 55.727
by Aetna, Inc. 01-21-00 12,000 668,725 55.727
by Aetna, Inc. 01-21-00 54,900 3,054,361 55.635
by Aetna, Inc. 01-21-00 107,600 5,996,236 55.727
by Aetna, Inc. 01-21-00 27,900 1,554,786 55.727
by Aetna, Inc. 01-21-00 68,000 3,789,443 55.727
by Aetna, Inc. 01-21-00 50,000 2,786,355 55.727
by Aetna, Inc. 01-24-00 11,000 612,512 55.683
by Aetna, Inc. 01-24-00 5,000 278,414 55.683
by Aetna, Inc. 01-24-00 61,500 3,424,498 55.683
by Aetna, Inc. 01-24-00 3,000 167,049 55.683
by Aetna, Inc. 01-24-00 9,000 501,146 55.683
by Aetna, Inc. 01-24-00 9,500 529,126 55.697
by Aetna, Inc. 01-24-00 12,500 696,036 55.683
by Aetna, Inc. 01-24-00 120,000 6,681,948 55.683
by Aetna, Inc. 01-24-00 14,000 779,561 55.683
by Aetna, Inc. 01-24-00 10,000 556,829 55.683
by Aetna, Inc. 01-24-00 13,000 723,878 55.683
by Aetna, Inc. 01-24-00 13,000 723,878 55.683
by Aetna, Inc. 01-24-00 10,000 556,829 55.683
by Aetna, Inc. 01-25-00 31,000 1,716,461 55.370
by Aetna, Inc. 01-25-00 11,000 609,067 55.370
by Aetna, Inc. 01-25-00 17,000 941,285 55.370
by Aetna, Inc. 01-25-00 9,000 498,327 55.370
by Aetna, Inc. 01-25-00 2,000 110,770 55.385
by Aetna, Inc. 01-25-00 18,000 996,655 55.370
by Aetna, Inc. 01-25-00 21,500 1,190,449 55.370
by Aetna, Inc. 01-25-00 23,000 1,273,503 55.370
by Aetna, Inc. 01-25-00 10,000 553,697 55.370
by Aetna, Inc. 01-25-00 16,000 885,915 55.370
by Aetna, Inc. 01-25-00 105,000 5,813,818 55.370
by Aetna, Inc. 01-25-00 112,000 6,201,406 55.370
by Aetna, Inc. 01-25-00 24,000 1,328,873 55.370
by Aetna, Inc. 01-25-00 15,000 830,545 55.370
by Aetna, Inc. 01-25-00 14,000 775,176 55.370
by Aetna, Inc. 01-25-00 14,000 775,176 55.370
by Aetna, Inc. 01-25-00 23,000 1,273,503 55.370
by Aetna, Inc. 01-25-00 13,000 719,806 55.370
by Aetna, Inc. 01-25-00 10,000 553,697 55.370
by Aetna, Inc. 01-26-00 4,500 248,332 55.185
by Aetna, Inc. 01-26-00 10,000 552,500 55.250
by Aetna, Inc. 01-26-00 57,500 3,169,544 55.123
by Aetna, Inc. 01-26-00 7,000 387,898 55.414
by Aetna, Inc. 01-27-00 15,500 856,375 55.250
by Aetna, Inc. 01-27-00 2,000 110,500 55.250
by Aetna, Inc. 01-27-00 1,000 55,250 55.250
by Aetna, Inc. 01-27-00 11,000 600,539 54.594
by Aetna, Inc. 01-27-00 18,000 991,049 55.058
by Aetna, Inc. 01-27-00 10,000 545,945 54.595
by Aetna, Inc. 01-27-00 21,000 1,141,971 54.380
by Aetna, Inc. 01-27-00 2,000 108,764 54.382
by Aetna, Inc. 01-27-00 2,500 133,846 53.538
by Aetna, Inc. 01-27-00 11,000 588,915 53.538
by Aetna, Inc. 01-27-00 5,000 271,896 54.379
by Aetna, Inc. 01-27-00 19,000 1,035,452 54.497
by Aetna, Inc. 01-27-00 46,500 2,569,590 55.260
by Aetna, Inc. 01-27-00 16,000 873,512 54.595
by Aetna, Inc. 01-27-00 13,000 705,891 54.299
by Aetna, Inc. 01-28-00 40,000 2,138,076 53.452
by Aetna, Inc. 01-28-00 3,000 160,356 53.452
by Aetna, Inc. 01-28-00 9,800 523,829 53.452
by Aetna, Inc. 01-28-00 89,500 4,794,515 53.570
by Aetna, Inc. 01-28-00 25,000 1,336,297 53.452
by Aetna, Inc. 01-28-00 29,800 1,596,460 53.572
by Aetna, Inc. 01-28-00 14,200 759,017 53.452
by Aetna, Inc. 01-31-00 9,000 479,294 53.255
by Aetna, Inc. 01-31-00 2,500 133,775 53.510
by Aetna, Inc. 01-31-00 70,700 3,765,121 53.255
by Aetna, Inc. 01-31-00 8,000 426,039 53.255
by Aetna, Inc. 02-01-00 39,000 2,147,730 55.070
by Aetna, Inc. 02-01-00 2,000 106,520 53.260
by Aetna, Inc. 02-01-00 11,000 605,770 55.070
by Aetna, Inc. 02-02-00 2,000 110,384 55.192
by Aetna, Inc. 02-02-00 2,600 146,438 56.322
by Aetna, Inc. 02-02-00 7,000 386,343 55.192
by Aetna, Inc. 02-02-00 45,500 2,523,826 55.469
by Aetna, Inc. 02-02-00 7,700 424,977 55.192
by Aetna, Inc. 02-03-00 27,600 1,537,477 55.706
by Aetna, Inc. 02-03-00 45,000 2,488,000 55.289
by Aetna, Inc. 02-03-00 8,200 454,157 55.385
by Aetna, Inc. 02-04-00 4,800 267,648 55.760
by Aetna, Inc. 02-04-00 53,000 2,942,099 55.511
by Aetna, Inc. 02-04-00 8,000 444,090 55.511
by Aetna, Inc. 02-07-00 27,000 1,503,765 55.695
by Aetna, Inc. 02-07-00 11,700 651,631 55.695
by Aetna, Inc. 02-07-00 3,200 179,232 56.010
by Aetna, Inc. 02-07-00 14,300 800,943 56.010
by Aetna, Inc. 02-07-00 18,500 1,036,185 56.010
by Aetna, Inc. 02-07-00 13,300 740,743 55.695
by Aetna, Inc. 02-07-00 11,000 612,645 55.695
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 5,000 240,965 48.193
by Aetna, Inc. 02-08-00 3,000 144,579 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 150,000 7,245,195 48.301
by Aetna, Inc. 02-08-00 4,000 192,772 48.193
by Aetna, Inc. 02-08-00 1,000 48,690 48.690
by Aetna, Inc. 02-08-00 1,000 48,690 48.690
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 13,000 620,868 47.759
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 2,000 96,386 48.193
by Aetna, Inc. 02-08-00 7,000 337,351 48.193
by Aetna, Inc. 02-08-00 14,000 674,702 48.193
by Aetna, Inc. 02-08-00 18,000 869,423 48.301
by Aetna, Inc. 02-08-00 3,000 144,579 48.193
by Aetna, Inc. 02-08-00 2,000 96,386 48.193
by Aetna, Inc. 02-08-00 2,000 96,120 48.060
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 2,000 96,386 48.193
by Aetna, Inc. 02-08-00 7,000 337,351 48.193
by Aetna, Inc. 02-08-00 5,000 229,675 45.935
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 6,000 289,158 48.193
by Aetna, Inc. 02-08-00 4,000 192,772 48.193
by Aetna, Inc. 02-08-00 2,000 95,872 47.936
by Aetna, Inc. 02-08-00 85,000 4,144,591 48.760
by Aetna, Inc. 02-08-00 3,000 144,579 48.193
by Aetna, Inc. 02-08-00 27,000 1,301,211 48.193
by Aetna, Inc. 02-08-00 2,000 95,518 47.759
by Aetna, Inc. 02-08-00 10,000 481,930 48.193
by Aetna, Inc. 02-08-00 85,000 4,096,405 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 5,000 240,965 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 7,000 337,351 48.193
by Aetna, Inc. 02-08-00 2,000 96,386 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 2,000 96,386 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 1,000 48,193 48.193
by Aetna, Inc. 02-08-00 25,000 1,204,825 48.193
by Aetna, Inc. 02-08-00 14,000 674,702 48.193
by Aetna, Inc. 02-08-00 49,500 2,385,553 48.193
by Aetna, Inc. 02-08-00 2,000 95,598 47.799
by Aetna, Inc. 02-08-00 15,000 731,398 48.760
by Aetna, Inc. 02-08-00 1,000 47,819 47.819
by Aetna, Inc. 02-08-00 129,000 6,290,027 48.760
by Aetna, Inc. 02-08-00 500 24,114 48.228
by Aetna, Inc. 02-08-00 2,000 96,448 48.224
by Aetna, Inc. 02-08-00 28,000 1,365,277 48.760
by Aetna, Inc. 02-08-00 11,000 536,359 48.760
by Aetna, Inc. 02-08-00 39,000 1,901,636 48.760
by Aetna, Inc. 02-08-00 53,000 2,584,275 48.760
by Aetna, Inc. 02-08-00 2,000 95,518 47.759
by Aetna, Inc. 02-08-00 17,000 821,122 48.301
by Aetna, Inc. 02-08-00 15,000 724,519 48.301
by Aetna, Inc. 02-09-00 117,000 5,187,207 44.335
by Aetna, Inc. 02-09-00 2,000 88,670 44.335
by Aetna, Inc. 02-09-00 6,000 275,685 45.948
by Aetna, Inc. 02-09-00 2,000 91,895 45.948
by Aetna, Inc. 02-09-00 3,000 133,005 44.335
by Aetna, Inc. 02-09-00 62,000 2,848,745 45.948
by Aetna, Inc. 02-09-00 4,000 173,990 43.498
by Aetna, Inc. 02-09-00 2,000 88,670 44.335
by Aetna, Inc. 02-09-00 2,000 91,895 45.948
by Aetna, Inc. 02-09-00 9,000 413,527 45.947
by Aetna, Inc. 02-09-00 7,200 319,213 44.335
by Aetna, Inc. 02-09-00 16,000 735,160 45.948
by Aetna, Inc. 02-09-00 4,000 177,340 44.335
by Aetna, Inc. 02-09-00 3,000 137,842 45.947
by Aetna, Inc. 02-10-00 1,000 42,072 42.072
by Aetna, Inc. 02-10-00 1,000 42,072 42.072
by Aetna, Inc. 02-10-00 1,000 42,072 42.072
by Aetna, Inc. 02-10-00 4,000 168,290 42.073
by Aetna, Inc. 02-10-00 2,000 84,145 42.073
by Aetna, Inc. 02-10-00 3,000 126,217 42.072
by Aetna, Inc. 02-10-00 5,000 210,362 42.072
by Aetna, Inc. 02-10-00 16,000 673,160 42.073
by Aetna, Inc. 02-10-00 8,000 327,431 40.929
by Aetna, Inc. 02-10-00 2,000 84,145 42.073
by Aetna, Inc. 02-10-00 20,000 841,450 42.073
by Aetna, Inc. 02-10-00 30,000 1,262,175 42.073
by Aetna, Inc. 02-10-00 1,000 41,074 41.074
by Aetna, Inc. 02-10-00 1,000 42,072 42.072
by Aetna, Inc. 02-10-00 15,000 631,050 42.070
by Aetna, Inc. 02-10-00 1,000 42,072 42.072
by Aetna, Inc. 02-10-00 113,000 4,754,192 42.072
by Aetna, Inc. 02-10-00 3,000 122,787 40.929
by Aetna, Inc. 02-10-00 8,000 327,431 40.929
by Aetna, Inc. 02-10-00 21,000 859,507 40.929
by Aetna, Inc. 02-10-00 9,000 368,360 40.929
by Aetna, Inc. 02-10-00 314,000 12,851,675 40.929
by Aetna, Inc. 02-10-00 6,000 245,573 40.929
by Aetna, Inc. 02-10-00 2,000 82,138 41.069
by Aetna, Inc. 02-10-00 4,000 163,716 40.929
by Aetna, Inc. 02-10-00 5,000 204,644 40.929
by Aetna, Inc. 02-10-00 9,000 368,360 40.929
by Aetna, Inc. 02-10-00 11,000 450,218 40.929
by Aetna, Inc. 02-10-00 25,000 1,023,222 40.929
by Aetna, Inc. 02-10-00 97,000 3,970,103 40.929
by Aetna, Inc. 02-10-00 3,000 122,787 40.929
by Aetna, Inc. 02-10-00 9,000 368,360 40.929
by Aetna, Inc. 02-10-00 5,000 204,644 40.929
by Aetna, Inc. 02-11-00 14,000 558,265 39.876
by Aetna, Inc. 02-11-00 17,000 678,832 39.931
by Aetna, Inc. 02-14-00 6,000 233,981 38.997
by Aetna, Inc. 02-14-00 30,000 1,169,907 38.997
by Aetna, Inc. 02-14-00 11,000 428,966 38.997
by Aetna, Inc. 02-14-00 29,000 1,158,089 39.934
by Aetna, Inc. 02-14-00 6,000 239,605 39.934
by Aetna, Inc. 02-14-00 3,000 118,305 39.435
by Aetna, Inc. 02-14-00 7,000 275,170 39.310
by Aetna, Inc. 02-14-00 30,400 1,185,506 38.997
by Aetna, Inc. 02-14-00 5,900 236,059 40.010
by Aetna, Inc. 02-14-00 7,600 296,376 38.997
by Aetna, Inc. 02-14-00 31,000 1,219,360 39.334
by Aetna, Inc. 02-14-00 3,000 117,742 39.247
by Aetna, Inc. 02-14-00 15,000 584,953 38.997
by Aetna, Inc. 02-18-00 5,000 194,675 38.935
by Aetna, Inc. 02-23-00 2,000 80,620 40.310
by Aetna, Inc. 02-28-00 57,000 2,330,445 40.885
by Aetna, Inc. 03-01-00 30,000 1,254,801 41.827
sl Aetna, Inc. 03-01-00 18,000 971,608 53.978
sl Aetna, Inc. 03-02-00 11,800 713,168 60.438
sl Aetna, Inc. 03-02-00 14,200 858,219 60.438
sl Aetna, Inc. 03-02-00 9,000 543,942 60.438
1
AET13D.doc
